BioPharma Resources

Drug Trial Radar · NCT06018337

A Study of DB-1303/BNT323 vs Investigator's Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Metastatic Breast Cancer (DYNASTY-Breast02)

A Phase 3, Randomized, Multi-center, Open-Label Study of DB-1303 Versus Investigator's Choice Chemotherapy in Human Epidermal Growth Factor Receptor 2 (HER2)-Low, Hormone Receptor Positive (HR+) Metastatic Breast Cancer Patients Whose Disease Has Progressed on Endocrine Therapy (ET) (DYNASTY-Breast02)

Last checked: Nov 19, 2026Latest source record: Sep 24, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 541 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

541

Actual

Start

Jan 18, 2024

Primary completion

Aug 12, 2026

Study completion Aug 2028

Sponsor

Lead sponsor
DualityBio Inc.Industry
Sponsor type
Industry
Collaborators
BioNTech SE
First posted
Aug 30, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this clinical trial is to assess the efficacy of DB-1303/BNT323 compared with investigator's choice chemotherapy in terms of progression-free survival (PFS) by blinded independent central review (BICR) in the HR+, HER2-low (immunohistochemistry \[IHC\]2+/in situ hybridization \[ISH\]- and IHC 1+) population.

Conditions

  • Metastatic Breast Cancer

Interventions

  • DB-1303/BNT323Drug

    IV

  • CapecitabineDrug

    Oral

  • PaclitaxelDrug

    IV

  • Nab-paclitaxelDrug

    IV

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Progression-free survival (PFS) in the HR+, HER2-low populationTime frame: Up to approximately 51 months

Locations

258 sites in 17 countries. Site status is shown where the registry gives one.

  • Research Site 1141-0

    Tucson, Arizona

  • Research Site 1114-0

    Fullerton, California

  • Research Site 1107-0

    Los Angeles, California

  • Research Site 1118-0

    Orange, California

  • Research Site 1143-0

    Sacramento, California

  • Research Site 1132-0

    Santa Barbara, California

  • Research Site 1137-0

    Aurora, Colorado

  • Research Site 1129-0

    Lone Tree, Colorado

  • Research Site 1154-0

    Jacksonville, Florida

  • Research Site 1145-0

    Miami, Florida

  • Research Site 1150-0

    Orange City, Florida

  • Research Site 1125-0

    Palm Bay, Florida

  • Research Site 1155-0

    Athens, Georgia

  • Research Site 1110-0

    Savannah, Georgia

  • Research Site 1147-0

    Chicago, Illinois

  • Research Site 1124-0

    Chicago Ridge, Illinois

  • Research Site 1152-0

    Fort Wayne, Indiana

  • Research Site 1106-0

    Merriam, Kansas

  • Research Site 1104-0

    Louisville, Kentucky

  • Research Site 1122-0

    Silver Spring, Maryland

  • Research Site 1109-0

    Kansas City, Missouri

  • Research Site 1158-0

    Camden, New Jersey

  • Research Site 1111-0

    Florham Park, New Jersey

  • Research Site 1157-0

    Sante Fe, New Mexico

  • Research Site 1148-0

    Staten Island, New York

  • Research Site 1105-0

    Westbury, New York

  • Research Site 1144-0

    Chapel Hil, North Carolina

  • Research Site 1138-0

    Akron, Ohio

  • Research Site 1160-0

    Cincinnati, Ohio

  • Research Site 1133-0

    Eugene, Oregon

  • Research Site 1126-0

    Tigard, Oregon

  • Research Site 1134-0

    Broomall, Pennsylvania

  • Research Site 1123-0

    Horsham, Pennsylvania

  • Research Site 1149-0

    Knoxville, Tennessee

  • Research Site 1102-0

    Nashville, Tennessee

  • Research Site 1159-0

    Nashville, Tennessee

  • Research Site 1101-0

    Dallas, Texas

  • Research Site 1116-0

    Denison, Texas

  • Research Site 1115-0

    Houston, Texas

  • Research Site 1117-0

    San Antonio, Texas

Showing 40 of 258 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.